Daptomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 31722-216

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Daptomycin (NDC 31722-216). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image
FDA Label Image

Daptomycinecartonlabel (Daptomycinecartonlabel)

FDA Label Image

Daptomycinecontainerlabel (Daptomycinecontainerlabel)

Daptomycinecontainerlabel (Daptomycinecontainerlabel)
This text is a description of Daptomycin, an injection with 500mg per vial, to be administered intravenously after reconstitution with 10mL of 0.9% Sodium Chloride Injection. The package insert provides complete information on dosage and administration. It must be refrigerated at 2°C to 8°C and any unused portion of the single-dose vial should be discarded. The U.S. contact number provided is 18664951995. The lot number is XKKX and the expiration date is MMIYYYY. It is manufactured by ASPIRO PHARMA LIMITED in India, and is distributed by Camber Pharmaceutical, Inc.*
FDA Label Image

Daptomycinestructure (Daptomycinestructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.